Pharmaceutical co-development services
Protagen specializes in Pharma development services in the fields of immuno-oncology and autoimmune disease. Via co-development projects with its strategic partners, Protagen enables effective, targeted immuno-therapeutic development for improved patient care.
Protagen is a lab services business that is at the forefront of immuno-profiling and the discovery of novel biomarkers for immuno-oncology, autoimmune disease, and other immune-driven diseases. Using its proprietary immuno-profiling platform (SeroTag®), and stratification arrays based on biomarker panels (NavigAID) to screen patient serum specimens, Protagen is able to provide:
- Better disease activity assessment
- Improved response prediction
- Patient monitoring
- The early detection of immune-related adverse events (irAEs)